Skip to main content

Advertisement

TABLE 2 Laboratory data from different groups

From: GnRH agonists to sustain the luteal phase in antagonist IVF cycles: a randomized prospective trial

 AHAHT1AHT2 
Retrieved oocytes (Mean ± SD)< 35 anni8,7 ± 4,59,2 ± 5,39,3 ± 4,2NS
≥35 anni7,8 ± 4,17,6 ± 4,37,3 ± 2,9NS
Inseminated oocytes (Mean ± SD)< 35 anni5,2 ± 2,15,3 ± 2,44,2 ± 1,4NS
≥35 anni5,7 ± 2,95,9 ± 2,66,1 ± 2,4NS
Embryos obtained (Mean ± SD)< 35 anni3,9 ± 1,83,9 ± 1,63,1 ± 0,9NS
≥35 anni4,1 ± 2,24,0 ± 2,04,2 ± 2,1NS
Transferred embryos (Mean ± SD)< 35 anni1,7 ± 0,61,7 ± 0,61,5 ± 0,7NS
≥35 anni2,2 ± 0,62,2 ± 0,72,3 ± 0,7NS
  1. AH Antagonist cycles with only Progesterone in luteal phase
  2. AHT1 Antagonist cycles with addition of luteal triptorelin as multiple injections
  3. AHT2 Antagonist cycles with addition of luteal triptorelin as single bolus